PHASE-II STUDY OF WEEKLY EDATREXATE AS 1ST-LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER - A NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP-STUDY
Ta. Vandenberg et al., PHASE-II STUDY OF WEEKLY EDATREXATE AS 1ST-LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER - A NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP-STUDY, Journal of clinical oncology, 11(7), 1993, pp. 1241-1244